title: Investigation of cigarette smoking among male schizophrenia patients.
abstract: Male schizophrenia patients are known to have a heavier smoking pattern compared with the general population. However, the mechanism for this association is not known, though hypothesis that smoking could alleviate symptomatology of schizophrenia and reduce side effects of antipsychotics has been suggested. The aims of this study were to validate the heavier smoking pattern among male schizophrenia patients and to investigate the possible mechanisms for the association. To enhance the reliability of the study, we recruited two large independent samples with 604 and 535 male Chinese schizophrenia patients, and compared their smoking pattern with that of 535 healthy male controls recruited from general population. Validated multiple indicators and multiple causes structure equation model and regression models were used to investigate the association of smoking with factors of schizophrenia symptomatology and with the usage of antipsychotics and their extra-pyramidal side effects (EPS). Schizophrenia patients had significantly heavier smoking pattern compared with healthy controls in our sample (42.4% vs. 16.8%, p<0.001 for current smoking prevalence; 23.5% vs. 43.3%, p<0.001 for smoking cessation rate; 24.5% vs. 3.0%, p<0.001 for heavy smoker proportion). Their smoking status was also found to be consistently and significantly associated with reduced negative factor scores for schizophrenia symptomatology (β = -0.123, p = 0.051 for sample-A; β = -0.103, p = 0.035 for sample-B; β = -0.082, p = 0.017 for the combined sample). However, no significant association was found between smoking and antipsychotics usage or risk of EPS. These results support that smoking is associated with improved negative symptoms, which could account for the heavier smoking pattern among schizophrenia patients.
authors: Research Division, Institute of Mental Health/Woodbridge Hospital, Singapore, Singapore ; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
authors: Jundong
authors: J
authors: Jiang
authors: Yuen Mei
authors: YM
authors: See
authors: Mythily
authors: M
authors: Subramaniam
authors: Jimmy
authors: J
authors: Lee
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D044466:Asian People; D016022:Case-Control Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D012044:Regression Analysis; D012559:Schizophrenia / Q000188:drug therapy / Q000208:ethnology / Q000503:physiopathology*; D012565:Schizophrenic Psychology; D012907:Smoking / Q000523:psychology*
chemical_list: D014150:Antipsychotic Agents
references: Synapse. 2000 Oct;38(1):10-6
references: 10941136
references: Am J Psychiatry. 1995 Mar;152(3):453-5
references: 7864277
references: Addict Behav. 1998 Mar-Apr;23(2):263-6
references: 9573430
references: J Clin Psychiatry. 2003 Jun;64(6):663-7
references: 12823080
references: Schizophr Res. 2002 Jul 1;56(1-2):47-54
references: 12084419
references: Am Heart J. 2005 Dec;150(6):1115-21
references: 16338246
references: Neuropsychopharmacology. 2012 Feb;37(3):660-8
references: 22048460
references: Schizophr Res. 2013 Jan;143(1):38-43
references: 23148897
references: Neuropsychopharmacology. 2008 Feb;33(3):480-90
references: 17443126
references: Eur Psychiatry. 2005 Jan;20(1):50-4
references: 15642444
references: J Nerv Ment Dis. 2002 Sep;190(9):604-10
references: 12357094
references: Hosp Community Psychiatry. 1994 Mar;45(3):204-6
references: 7910577
references: Psychiatry Res. 2010 Aug 15;178(3):461-6
references: 20493556
references: Subst Abus. 2001 Sep;22(3):175-186
references: 12466677
references: Schizophr Res. 2012 May;137(1-3):246-50
references: 22356801
references: Schizophr Res. 2005 Jul 1;76(1):113-8
references: 15927805
references: Hosp Community Psychiatry. 1988 Nov;39(11):1172-7
references: 2906320
references: Aust N Z J Psychiatry. 2006 Jun-Jul;40(6-7):575-80
references: 16756583
references: Schizophr Res. 2003 Dec 1;65(1):47-55
references: 14623374
references: Schizophr Bull. 2006 Oct;32(4):692-700
references: 16469942
references: Schizophr Res. 2005 Nov 15;79(2-3):323-35
references: 15961287
references: Acta Psychiatr Scand Suppl. 1970;212:11-9
references: 4917967
references: Am J Psychiatry. 1992 Sep;149(9):1189-94
references: 1503131
references: J Clin Psychiatry. 2002 Sep;63(9):812-6
references: 12363123
references: Curr Opin Psychiatry. 2010 Mar;23(2):112-9
references: 20051860
references: Arch Gen Psychiatry. 1982 Apr;39(4):486-7
references: 6121550
references: Schizophr Res. 1992 Dec;8(2):93-102
references: 1360812
references: Schizophr Res. 2007 Sep;95(1-3):236-46
references: 17662578
references: J Neural Transm Suppl. 2006;(70):177-80
references: 17017527
references: Am J Psychiatry. 1999 Nov;156(11):1751-7
references: 10553739
references: Am J Psychiatry. 2000 Apr;157(4):632-4
references: 10739427
references: Schizophr Res. 2005 Jul 15;76(2-3):135-57
references: 15949648
references: Biol Psychiatry. 1997 Jul 1;42(1):1-5
references: 9193735
references: PLoS One. 2012;7(2):e30937
references: 22347412
references: Neuropsychopharmacology. 2013 May;38(6):968-75
references: 23303043
references: Clin Neuropharmacol. 1987 Aug;10(4):376-83
references: 3503681
references: Br J Psychiatry. 2005 Mar;186:215-21
references: 15738502
references: Am J Psychiatry. 1998 Nov;155(11):1490-501
references: 9812108